Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin- dependent kinases (CDKs)
Preprint in Research Square (January 2024)
The most recent citing publications are shown below. View all 95 publications that cite this research output on Dimensions.
The Anticancer Effect of Theranekron® on Androgen-Dependent Prostate Cancer Cells
Article in Turkish Journal of Pharmaceutical Sciences (January 2024)
Identification of metabolism-related gene signature in lung adenocarcinoma
Article in Medicine (November 2023)